Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Sexually Transmitted Diseases

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    June 2017
  1. GE Y, Christensen P, Luna E, Armylagos D, et al
    Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
    PubMed     Text format     Abstract available


    May 2017
  2. GUO M, Khanna A, Wang J, Dawlett MA, et al
    Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
    PubMed     Text format     Abstract available


  3. PRINTZ C
    CDC recommends only 2 HPV doses for younger adolescents.
    Cancer. 2017;123:1485.
    PubMed     Text format    


  4. FAKHRY C, Westra WH, Wang SJ, van Zante A, et al
    The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Cancer. 2017;123:1566-1575.
    PubMed     Text format     Abstract available


    April 2017
  5. ZUMSTEG ZS, Lok BH, Ho AS, Drill E, et al
    The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Cancer. 2017;123:1345-1353.
    PubMed     Text format     Abstract available


    February 2017
  6. BEADLE BM
    The impact of HPV testing for oropharyngeal cancers: Why the addendum matters.
    Cancer. 2017 Feb 27. doi: 10.1002/cncy.21842.
    PubMed     Text format    


  7. TABERNA M, Inglehart RC, Pickard RK, Fakhry C, et al
    Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer.
    Cancer. 2017 Feb 14. doi: 10.1002/cncr.30564.
    PubMed     Text format     Abstract available


    January 2017
  8. SHER DJ, Rusthoven CG, Khan SA, Fidler MJ, et al
    National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:273-282.
    PubMed     Text format     Abstract available


    December 2016
  9. OVESTAD IT, Dalen I, Hansen E, Loge JL, et al
    Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Cancer. 2016 Dec 5. doi: 10.1002/cncy.21807.
    PubMed     Text format     Abstract available


  10. BAUMAN JE, Cohen E, Ferris RL, Adelstein DJ, et al
    Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30449.
    PubMed     Text format     Abstract available


    November 2016
  11. DE BROT L, Pellegrini B, Moretti ST, Carraro DM, et al
    Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix.
    Cancer. 2016 Nov 21. doi: 10.1002/cncy.21789.
    PubMed     Text format     Abstract available


    October 2016
  12. PATADJI S, Li Z, Pradhan D, Zhao C, et al
    Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution.
    Cancer. 2016 Oct 24. doi: 10.1002/cncy.21791.
    PubMed     Text format     Abstract available


  13. DOXTADER EE, Brainard JA, Underwood D, Chute DJ, et al
    Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
    Cancer. 2016 Oct 12. doi: 10.1002/cncy.21783.
    PubMed     Text format     Abstract available


    September 2016
  14. SILVER MI, Schiffman M, Fetterman B, Poitras NE, et al
    The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
    Cancer. 2016 Sep 22. doi: 10.1002/cncr.30277.
    PubMed     Text format     Abstract available


    August 2016
  15. MAZUL AL, Taylor JM, Divaris K, Weissler MC, et al
    Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
    Cancer. 2016 Aug 29. doi: 10.1002/cncr.30312.
    PubMed     Text format     Abstract available


  16. JIMENO A, Machiels JP, Wirth L, Specenier P, et al
    Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30256.
    PubMed     Text format     Abstract available


    July 2016
  17. BURGER EA, Lee K, Saraiya M, Thompson TD, et al
    Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines.
    Cancer. 2016;122:2057-66.
    PubMed     Text format     Abstract available


  18. HORNE ZD, Glaser SM, Vargo JA, Ferris RL, et al
    Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Cancer. 2016;122:2021-30.
    PubMed     Text format     Abstract available


    June 2016
  19. GARDEN AS, Fuller CD, Rosenthal DI, William WN Jr, et al
    Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2016;122:1702-7.
    PubMed     Text format     Abstract available


    May 2016
  20. BISHOP JA, Ha PK
    Human papillomavirus detection in a "Digital" age.
    Cancer. 2016;122:1502-4.
    PubMed     Text format    


  21. BIRON VL, Kostiuk M, Isaac A, Puttagunta L, et al
    Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Cancer. 2016;122:1544-51.
    PubMed     Text format     Abstract available


  22. CRACCHIOLO JR, Baxi SS, Morris LG, Ganly I, et al
    Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
    Cancer. 2016;122:1523-32.
    PubMed     Text format     Abstract available


  23. PATEL MA, Blackford AL, Rettig EM, Richmon JD, et al
    Rising population of survivors of oral squamous cell cancer in the United States.
    Cancer. 2016;122:1380-7.
    PubMed     Text format     Abstract available


  24. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    PubMed     Text format     Abstract available


    March 2016
  25. WRIGHT BJ, Conlin AK, Allen HL, Tsui J, et al
    What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.
    Cancer. 2016;122:791-7.
    PubMed     Text format     Abstract available


    February 2016
  26. MCDOWELL LJ, Young RJ, Johnston ML, Tan TJ, et al
    p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    Cancer. 2016 Feb 16. doi: 10.1002/cncr.29901.
    PubMed     Text format     Abstract available


  27. FRAKES JM, Naghavi AO, Demetriou SK, Strom TJ, et al
    Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Cancer. 2016;122:634-41.
    PubMed     Text format     Abstract available


    January 2016

  28. Numbers game: Researchers explore whether fewer than 3 doses of HPV vaccine are effective.
    Cancer. 2016;122:11-2.
    PubMed     Text format    


    December 2015
  29. BYCHKOVSKY BL, Ferreyra ME, Strasser-Weippl K, Herold CI, et al
    Cervical cancer control in Latin America: A call to action.
    Cancer. 2015 Dec 15. doi: 10.1002/cncr.29813.
    PubMed     Text format     Abstract available


    October 2015
  30. SCHENKER Y, Arnold RM, Bauman JE, Heron DE, et al
    An enhanced role for palliative care in the multidisciplinary approach to high-risk head and neck cancer.
    Cancer. 2015 Oct 27. doi: 10.1002/cncr.29754.
    PubMed     Text format    


  31. QIAN G, Jiang N, Wang D, Newman S, et al
    Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Cancer. 2015;121:3600-11.
    PubMed     Text format     Abstract available


  32. TEMKIN SM, Seibel NL
    Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.
    Cancer. 2015;121:3395-402.
    PubMed     Text format     Abstract available


  33. DAHLSTROM KR, Li G, Hussey CS, Vo JT, et al
    Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
    Cancer. 2015;121:3455-64.
    PubMed     Text format     Abstract available


    September 2015
  34. PRINTZ C
    HPV vaccine protects at multiple sites, even for some previously exposed.
    Cancer. 2015;121:2863.
    PubMed     Text format    


    August 2015
  35. BRAR H, Covens A
    Trends in cervical intraepithelial neoplasia Grade 2+ after human papillomavirus vaccination: The devil is in the details.
    Cancer. 2015;121:2674-7.
    PubMed     Text format    


  36. PRINTZ C
    ACS report: Progress lags in some cancer control efforts.
    Cancer. 2015;121:2478-9.
    PubMed     Text format    


  37. HAJDU SI, Vadmal M, Tang P
    A note from history: Landmarks in history of cancer, part 7.
    Cancer. 2015;121:2480-513.
    PubMed     Text format     Abstract available


  38. KEANE FK, Chen YH, Neville BA, Tishler RB, et al
    Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Cancer. 2015;121:2594-602.
    PubMed     Text format     Abstract available


    July 2015
  39. PRINTZ C
    Physicians say HPV testing alone can screen for cervical cancer.
    Cancer. 2015;121:2105.
    PubMed     Text format    


    June 2015
  40. HARIRI S, Johnson ML, Bennett NM, Bauer HM, et al
    Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.
    Cancer. 2015 Jun 22. doi: 10.1002/cncr.29266.
    PubMed     Text format     Abstract available


  41. GRAHAM DM, Isaranuwatchai W, Habbous S, de Oliveira C, et al
    A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.
    Cancer. 2015;121:1785-92.
    PubMed     Text format     Abstract available


  42. SINHA P, Piccirillo JF, Kallogjeri D, Spitznagel EL, et al
    The role of postoperative chemoradiation for oropharynx carcinoma: a critical appraisal of the published literature and National Comprehensive Cancer Network guidelines.
    Cancer. 2015;121:1747-54.
    PubMed     Text format     Abstract available


    May 2015
  43. WEINMANN S, Williams AE, Kamineni A, Buist DS, et al
    Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007.
    Cancer. 2015 May 18. doi: 10.1002/cncr.29445.
    PubMed     Text format     Abstract available


    January 2015
  44. IYER NG, Tan DS, Tan V, Wang W, et al
    Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Cancer. 2015 Jan 29. doi: 10.1002/cncr.29251.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: